Who owns DIANTHUS THERAPEUTICS INC?
- Ticker: DNTH
- CUSIP Number: 252828108
Tip: Access positions for across all investors
Analyze quarterly positions in Dianthus Therapeutics with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Dianthus Therapeutics stock
Who bought or sold DIANTHUS THERAPEUTICS INC this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Fairmount Funds Management | 1.9M | $20M | 0% | Dec 2023 |
|
| 5AM Venture Management | 1.5M | $15M | 0% | Dec 2023 |
|
| Avidity Partners Management | 1.2M | $13M | 0% | Dec 2023 |
|
| VR Adviser | 928k | $9.6M | 0% | Dec 2023 |
|
| Octagon Capital Advisors | 554k | $5.8M | 15% | Dec 2023 |
|
| Tang Capital Management | 504k | $5.2M | -15% | Dec 2023 |
|
| Nantahala Capital Management | 328k | $3.4M | -3% | Dec 2023 |
|
| Atlas Venture Life Science Advisors | 237k | $2.5M | 0% | Dec 2023 |
|
| Alphabet | 209k | $6.3M | 0% | Mar 2024 |
|
| Vanguard Group | 154k | $1.6M | 21% | Dec 2023 |
|
| Fred Alger Management | 41k | $425k | 100% | Dec 2023 |
|
| Millennium Management | 34k | $353k | 100% | Dec 2023 |
|
| Laurion Capital Management | 26k | $273k | -28% | Dec 2023 |
|
| Hussman Econometrics Advisors | 21k | $630k | 100% | Mar 2024 |
|
| Arrowpoint Asset Management | 21k | $216k | 0% | Dec 2023 |
|
| Citigroup | 17k | $181k | 350% | Dec 2023 |
|
| Jane Street | 16k | $163k | 100% | Dec 2023 |
|
| Bessemer | 15k | $154k | 0% | Dec 2023 |
|
| Dimensional Fund Advisors | 15k | $153k | 100% | Dec 2023 |
|
| Bank of New York Mellon | 8.4k | $253k | 100% | Mar 2024 |
|
| Bank of America Corporation | 4.1k | $43k | 3284% | Dec 2023 |
|
| ADAR1 Capital Management | 481.00 | $5.0k | 100% | Dec 2023 |
|
| UBS Group | 380.00 | $4.0k | 19% | Dec 2023 |
|
| Royal Bank of Canada | 335.00 | $4.0k | -1% | Dec 2023 |
|
| Wells Fargo & Company | 74.00 | $768.956200 | 48% | Dec 2023 |
|
| Jpmorgan Chase & Co | 41.00 | $425.998200 | 0% | Dec 2023 |
|
| Barclays | 3.00 | $0 | 100% | Dec 2023 |
|
| Institutional & Family Asset Management | 3.00 | $30.999900 | 0% | Dec 2023 |
|
Who sold out of Dianthus Therapeutics?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Citadel Advisors | Sep 2023 | 106k | $1.4M |